Fresenius SE & Co. KGaA (LON:0OO9)

London flag London · Delayed Price · Currency is GBP · Price in EUR
43.08
+0.56 (1.32%)
At close: May 16, 2025
44.76%
Market Cap 21.00B
Revenue (ttm) 18.52B
Net Income (ttm) 353.03M
Shares Out n/a
EPS (ttm) 0.63
PE Ratio 59.49
Forward PE 13.05
Dividend 0.84 (1.95%)
Ex-Dividend Date May 26, 2025
Volume 238,697
Average Volume 252,550
Open 42.95
Previous Close 42.52
Day's Range 42.39 - 43.08
52-Week Range 27.27 - 44.00
Beta 0.94
RSI 63.34
Earnings Date Aug 6, 2025

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; e... [Read more]

Industry Miscellaneous Health And Allied Services, Not Elsewhere Classified
Founded 1912
Employees 176,486
Stock Exchange London Stock Exchange
Ticker Symbol 0OO9
Full Company Profile

Financial Performance

Financial numbers in EUR Financial Statements

News

There is no news available yet.